A sclerostin-targeting polydopamine nanoplatform promotes osteogenesis and attenuates ovariectomy-induced bone loss by reducing ferroptosis-like injury

Osteoporosis is characterized by reduced bone mass, disrupted trabecular microarchitecture and increased fracture risk. Although sclerostin inhibition is an established bone-anabolic strategy, systemic blockade may raise safety concerns and conventional drug delivery to bone remains inefficient. Here, we developed a sclerostin-targeting, lipid-coated polydopamine nanoplatform loaded with N-oleoyl-L-serine (OS) and modified with the sclerostin-targeting aptamer Aptscl56 (PDA@NLipo-Aptscl56). The formulation showed a uniform nanoscale morphology, negative surface charge, favorable colloidal stability, efficient N-oleoyl-L-serine loading, measurable Aptscl56 conjugation and sustained release behavior. In primary bone marrow mesenchymal stem cells (BMSCs), PDA@NLipo-Aptscl56 exhibited good biocompatibility and enhanced osteogenic differentiation, as indicated by increased alkaline phosphatase activity, matrix mineralization and upregulation of osteogenic markers including ALP, RUNX2, OSX and OPN. Single-component controls demonstrated that PDA alone and free Aptscl56 had limited osteogenic effects, whereas OS alone and non-targeted PDA@NLipo-PEG produced moderate effects; the complete PDA@NLipo-Aptscl56 formulation exerted the strongest osteogenic activity. In ovariectomized mice, PDA@NLipo-Aptscl56 improved femoral trabecular bone parameters and histological mineralization. Proteomic analysis suggested treatment-associated changes in ferroptosis- and mitochondrial respiratory-chain-related proteins, with Uqcrfs1 emerging as a high-degree candidate protein within a mitochondrial protein interaction network. Mechanistically, PDA@NLipo-Aptscl56 reduced ferroptosis-like injury in OVX bone tissue and RSL3-treated osteoblasts, as reflected by restored GPX4/FTH1/FTL expression, reduced ACSL4 expression, and decreased Fe 2+ and 4-HNE levels. Uqcrfs1 overexpression partially attenuated these protective effects, supporting its involvement in the anti-ferroptotic response to PDA@NLipo-Aptscl56. Representative fluorescence biodistribution and safety analyses further supported the bone-targeting tendency and preliminary biosafety of the formulation. These findings indicate that PDA@NLipo-Aptscl56 is a promising bone-targeted nanoplatform for promoting osteogenesis and attenuating OVX-induced bone loss, partly through suppression of ferroptosis-like oxidative injury.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-19
DOI
https://doi.org/10.1038/s41598-026-80076-1
Primary Topic
Bone Metabolism and Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A sclerostin-targeting polydopamine nanoplatform promotes osteogenesis and attenuates ovariectomy-induced bone loss by reducing ferroptosis-like injury

周孜辉, Dengshuo Sun, Jian Chen, Shengyang Ge
Scientific Reports
Bone Metabolism and Diseases
article

A sclerostin-targeting polydopamine nanoplatform promotes osteogenesis and attenuates ovariectomy-induced bone loss by reducing ferroptosis-like injury

周孜辉, Dengshuo Sun, Jian Chen, Shengyang Ge
article en

Abstract

Osteoporosis is characterized by reduced bone mass, disrupted trabecular microarchitecture and increased fracture risk. Although sclerostin inhibition is an established bone-anabolic strategy, systemic blockade may raise safety concerns and conventional drug delivery to bone remains inefficient. Here, we developed a sclerostin-targeting, lipid-coated polydopamine nanoplatform loaded with N-oleoyl-L-serine (OS) and modified with the sclerostin-targeting aptamer Aptscl56 (PDA@NLipo-Aptscl56). The formulation showed a uniform nanoscale morphology, negative surface charge, favorable colloidal stability, efficient N-oleoyl-L-serine loading, measurable Aptscl56 conjugation and sustained release behavior. In primary bone marrow mesenchymal stem cells (BMSCs), PDA@NLipo-Aptscl56 exhibited good biocompatibility and enhanced osteogenic differentiation, as indicated by increased alkaline phosphatase activity, matrix mineralization and upregulation of osteogenic markers including ALP, RUNX2, OSX and OPN. Single-component controls demonstrated that PDA alone and free Aptscl56 had limited osteogenic effects, whereas OS alone and non-targeted PDA@NLipo-PEG produced moderate effects; the complete PDA@NLipo-Aptscl56 formulation exerted the strongest osteogenic activity. In ovariectomized mice, PDA@NLipo-Aptscl56 improved femoral trabecular bone parameters and histological mineralization. Proteomic analysis suggested treatment-associated changes in ferroptosis- and mitochondrial respiratory-chain-related proteins, with Uqcrfs1 emerging as a high-degree candidate protein within a mitochondrial protein interaction network. Mechanistically, PDA@NLipo-Aptscl56 reduced ferroptosis-like injury in OVX bone tissue and RSL3-treated osteoblasts, as reflected by restored GPX4/FTH1/FTL expression, reduced ACSL4 expression, and decreased Fe 2+ and 4-HNE levels. Uqcrfs1 overexpression partially attenuated these protective effects, supporting its involvement in the anti-ferroptotic response to PDA@NLipo-Aptscl56. Representative fluorescence biodistribution and safety analyses further supported the bone-targeting tendency and preliminary biosafety of the formulation. These findings indicate that PDA@NLipo-Aptscl56 is a promising bone-targeted nanoplatform for promoting osteogenesis and attenuating OVX-induced bone loss, partly through suppression of ferroptosis-like oxidative injury.

Scientific Reports
Shanghai Jiao Tong University (CN), Fudan University (CN), Ruijin Hospital (CN), Tongren Hospital (CN)
Bone Metabolism and Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon